How Many Covid Vaccines In Clinical Trials

In November 2020, the Center for Genetic Engineering and Biotechnology of Cuba launched a trial on a coronavirus vaccine called Abdala. The Abdala vaccine consists of a piece of the coronavirus spike protein called the receptor binding domain, and is delivered in three doses. On Feb. 1, the center held a press conference to announce the start of a Phase 2 trial. A Phase 3 trial involving up to 48,000 participants was launched on March 18. On May 12, while the Phase 3 trial was still underway, the Cuban government began rolling out Abdala in a mass vaccination campaign, in the hopes of reining in a surge of cases. On June 21, Cuban officials reported that Abdala had an efficacy of 92.28 percent.

The Cuban government granted emergency use authorization for the vaccine on July 9. Abdala is one of two Cuban vaccines tested in a Phase 1/2 clinical trial to assess their ability to increase immunity in those who have already had Covid-19. Starting in August 2020, CanSino began running Phase 3 trials in a number of countries, including Pakistan, Russia, Mexico and Chile. On Feb. 25, China announced the approval of the CanSino vaccine for general use. The company announced that its one-shot vaccine had an efficacy rate of 65.28 percent at preventing all symptomatic Covid-19 cases.

But on April 1, CanSino's chief scientific officer said that the efficacy of its vaccine could drop over time. He also floated the idea of using a booster shot six months after the first dose, though more clinical trial data is needed. Reuters reported on Aug. 5 that this drop could be as much as around 30 percent after six months.

Preliminary findings from its phase one trials showed that healthy subjects—including elderly patients—produced coronavirus antibodies and a reaction from T cells, another part of the human immune response. The company also announced plans to test the safety and efficacy of a booster shot that would be delivered a year after the first pair of vaccine doses, according to CNBC. On March 23, CanSino announced that it had won approval for a clinical trial of an inhaled version of the vaccine.

Chief Executive Yu Xuefeng said on June 2 that this version is now in Phase 2 trials. Preliminary findings from the Phase 1 trial suggest that the inhaled vaccine was effective at stimulating an immune response, and that an injected dose followed by an inhaled dose may yield the best results. Researchers have also begun to test whether giving alternating doses of vaccines from CanSino and Anhui Zhifei Longcom can boost their effectiveness. On June 9, Reuters reported that the CanSino vaccine is being tested as a booster shot.

Results from a Chinese study, released on Sept. 7, suggested that getting the CanSino booster shot after the Sinovac vaccine produced a stronger antibody response compared to a third shot of the Sinovac vaccine. CanSino announced on Sept. 26 that a trial in children age 6 to 17 yielded positive results. On June 1, Moderna announced that it has applied for full FDA approval of its COVID-19 vaccine for use in people age 18 and older. The company also plans to file for emergency use authorization for teens ages 12 to 17. A study of clinical trials among adolescents in this age group shows that its vaccine is safe and 100 percent effective. The study also showed the vaccine is 93 percent effective among participants in this age group two weeks after the first dose.

Researchers at City of Hope, a California biomedical research institute, created a vaccine based on a weakened form of a virus called Modified Vaccinia Ankara, or MVA for short. They added two coronavirus genes to the MVA virus — one for the spike protein, and one for another protein called nucleocapsid. They are testing the vaccine specifically for people with immune systems impaired by cancer and other disorders. Many of them do not produce a strong immune response to authorized vaccines based on mRNA. In September 2021, researchers launched a Phase 2 trial, giving the vaccine to volunteers with blood cancer who have received a bone marrow transplant or a form of immunotherapy called CAR-T.

Before the pandemic, the Pennsylvania-based company Inovio developed DNA-based vaccines that are delivered into the skin with electric pulses from a hand-held device. They are running clinical trials for vaccines against a number of diseases, including HIV, Zika, and several forms of cancer. At the start of the pandemic, Inovio developed a DNA vaccine against the spike protein on the coronavirus. A Phase 1 trial, published in December, did not uncover any serious adverse effects, and measured an immune response in all 38 volunteers.

Although progress has been made over the past decades in clinical trial transparency, and there are some successes for COVID-19 vaccines, there is still much room for improvement. The lack of adequate transparency about COVID-19 vaccine trials and their regulation cannot be dismissed as unfortunate, stubborn problems emblematic of the present culture in biomedicine. In a time of increasing public scrutiny, transparency of regulatory decision making leading to the approval of drug treatments and vaccines for COVID-19 is important to ensure patient and stakeholder trust. It is a scientific, moral and ethical imperative that access to complete trial data of these global public health interventions is urgently granted to patients, researchers and other key stakeholders. Finally, clinical trials occurred at different times and in different countries — which means that the prevalence of viral variants also differed. Pfizer-BioNTech's and Moderna's vaccines were tested before variants of concern were widely circulating, making it harder to know how effective they are against variants.

Three months agowe described the existing data on vaccines and variants, including the lack of clinical trial evidence for most vaccine/variant combinations. Studies fromEnglandandScotlandsuggest Pfizer and AstraZeneca vaccines offer somewhat reduced protection against infection by the highly transmissible Delta variant, but similar protection against severe illness. On Nov. 5, Turkey's Erciyes University announced they had begun injecting volunteers with an inactivated coronavirus vaccine called ERUCOV-VAC. It was the first clinical trial of a coronavirus vaccine developed in Turkey.

On Dec. 14, 2020, the president of the university said that the Phase 1 trial was complete. On June 23, 2021, Turkish president Recep Tayyip Erdoğan announced that the vaccine, renamed Turkovac, has entered a Phase 3 trial. In July, the researchers registered a Phase 2 trial to evaluate the vaccine as a booster shot. The Chinese company CanSino Biologics developed Convidecia in partnership with the Institute of Biology at the country's Academy of Military Medical Sciences. Last May, researchers published promising results from a Phase 1 safety trial on Convidecia, and in July they reported that their Phase 2 trials demonstrated the vaccine produced a strong immune response.

On Nov. 9, 2020, New York-based Pfizer and the German company BioNTech made history by announcing that their coronavirus vaccine had an efficacy rate of over 90 percent, far surpassing expectations. Just over a month later, on Dec. 11, the Food and Drug Administration granted the vaccine, known as Comirnaty, the first emergency use authorization ever given by the United States to a coronavirus vaccine. On Aug. 23, 2021, the F.D.A. granted full approval to the Pfizer-BioNTech vaccine, for people 16 and older, and on Sep. 22, the agency authorized a third dose as a booster for people age 65 and older, and other populations at high risk.

It is also 85 percent effective in people 65 and older and 100 percent effective at preventing severe cases of the disease. The company also said that real-world evidence and data from its clinical trials show that its single-dose vaccine remains effective against COVID-19. The press release cited a study published to a preprint server, which shows that the vaccine remains 79 percent effective in preventing COVID-19 and 81 percent effective in preventing hospitalizations. Johnson & Johnson said these data are consistent with findings from its clinical trials, which showed 75 percent efficacy against severe disease and 89 percent efficacy against hospitalization. Researchers at the Institute of Medical Biology at the Chinese Academy of Medical Sciences, which has invented vaccines for polio and hepatitis A, created an inactivated coronavirus vaccine. In May 2020, they launched a Phase 1 trial on 192 volunteers which indicated the vaccine was safe and produced an immune response.

A Phase 2 trial followed on 750 volunteers, which led the researchers to select a two-week spacing between the two doses of the vaccine. In December the researchers launched a Phase 3 trial on up to 34,020 volunteers in Brazil and Malaysia. On June 9, Chinese government newspaper Science and Technology Daily reported that the vaccine received emergency use authorization.

On Dec. 30, Sinopharm announced that the vaccine had an efficacy of 79.34 percent, leading the Chinese government to give it approval. On May 7, 2021, the World Health Organization put forward a similar efficacy estimate of 78.1 percent and gave the vaccine emergency use authorization. On Aug. 3, Bloomberg reported that results from a Hungarian study showed that the vaccine failed to produce enough antibodies in more than one quarter of elderly people.

Results from a Peru trial suggest that the vaccine was 50.4 percent effective in preventing infections among healthcare workers, Reuters reported on Aug. 13. On Sept. 11, 2021, COVAXX registered a Phase 1 trial in Taiwan which led to 100 percent of volunteers producing antibodies without any serious side effects. A Phase 2/3 trial is planned to launch in Brazil, India and other countries. On Nov. 25, Covaxx announced agreements with countries including Brazil, Ecuador, and Peru to deliver more than 140 million doses for $2.8 billion. In January, the company announced they were also starting preclinical research on a vaccine tailored specifically to newly emerged coronavirus variants that could potentially evade conventional vaccines.

In a June 21 press release, Vaxxinity said it expected to deliver the vaccine by the end of the summer, which did not come to pass. The researchers registered a Phase 1 trial on July 20 to assess the effectiveness of a third dose of its vaccine in those who have already received two. But in August, Taiwan regulators rejected an application for emergency approval of the vaccine after it failed to meet their standards on neutralizing antibodies. Last spring, researchers at the University of Washington developed a nanoparticle studded with pieces of the coronavirus spike protein.

The South Korean vaccine company SK Bioscience licensed the vaccine, called GBP510. After partnering with GSK, they launched a Phase 1/2 trial of the vaccine in February 2021. It is the second vaccine SK Bioscience has put into trials, after launching a study on another protein-based vaccine called NBP2001. SK Bioscience has received $210.1 million from the Coalition for Epidemic Preparedness Innovations for the development of GBP510.

In August, the company launched a Phase 3 trial, comparing GBP510 to AstraZeneca's Vaxzevria vaccine. Phase III clinical trials are critical to understanding whether vaccines are safe and effective. In Phase III, participants and most of the study investigators do not know who has received the vaccine and who received the placebo.

Participants are then followed to see how many in each group get the disease. Assessing short- and long-term safety is also a major goal of phase 3 trials. Phase II clinical trials continue to assess safety and immune responses but in a larger number and more diverse group of volunteers, typically one to several hundred people. Phase II trials may include target populations of a specific age or sex, or those with underlying medical conditions.

Vaccines for children start with adult volunteers and move to progressively younger groups of children. Different types of immune responses are often measured, including antibodies and cell-mediated immunity, but phase II trials do not assess how well a vaccine actually works. Additionally, there is a need for transparency around any deliberations regarding the length of follow-up necessary to adequately assess efficacy and safety prior to licensure.

Pfizer has already submitted its initial data on the safety and efficacy of its vaccine for children in that age group. The company said at the time that an analysis of its clinical trials of 2,268 participants shows the vaccine is safe and elicits "robust" neutralizing antibodies. The vaccine follows a two-dose regimen of 10 milligram doses—a third of the dosage that is given to adults. The company said at the time that an analysis of its clinical trial of 2,268 participants shows the vaccine is safe and elicits "robust" neutralizing antibodies. The Chumakov Center at the Russian Academy of Sciences developed an inactivated coronavirus vaccine called CoviVac.

On Oct. 14, 2020, Tass reported that clinical trials of the vaccine would begin in Kirov and St. Petersburg on Oct. 19. On Feb. 20, 2021, Russia approved the vaccine for domestic use, despite the fact that the Chumakov Center only later began a Phase 3 trial. On June 3, the director of the Chumakov Center said the trial was still underway and it was not yet possible to speak of the vaccine's efficacy.

The director said on Aug. 24 that the Chumakov Center is working on a modified version of the vaccine tailored for new variants, and that they plan to double the production capacity for CoviVac to 2.5 million doses per month. The director told Tass in October that a trial for adults aged 60 and older could begin soon. Shafa Pharmed Pars, an Iranian pharmaceutical company, developed a vaccine made of inactivated coronaviruses. Results from preclinical trials showed that the vaccine was safe and effective in animals. Known as COVIran Barekat, it entered a Phase 1 trial at the end of December, becoming the first vaccine developed in Iran to go into clinical testing.

COVIran Barekat began a Phase 3 trial on April 25, 2021, and on June 14, the Iranian government announced it had authorized the vaccine, despite the fact that many volunteers in the Phase 3 trial had not yet received their second dose. On June 25, Ayatollah Khamenei received the COVIran Barekat vaccine on television. As part of the European Union-funded PREVENT-nCoV consortium, a team of biotechnology companies and research laboratories developed a vaccine against Covid-19. The vaccine, called ABNCoV2, uses technology from consortium members AdaptVac and ExpreS2ion, among others. After promising preclinical results in primates, Bavarian Nordic announced that it would proceed with a Phase 1/2 trial of the vaccine in the Netherlands. On Aug. 9, the researchers said that the trial showed ABNCoV2 produced high levels of antibodies without dangerous side effects.

Later that month, Bavarian Nordic launched Phase 2 trials of the vaccine, both as an initial protection against Covid-19 and as a booster for other vaccines. Maryland-based Altimmune is a biopharmaceutical company that focuses on developing vaccines delivered by nasal spray. They developed a nasal spray vaccine for Covid-19, delivering the Ad5 adenovirus to the airway. Studies on the immune system suggests that a nasal spray could be more effective for blocking the transmission of the virus than vaccines given by injection.

In a study on mice, Altimmune researchers found that a single dose of the vaccine gave complete protection from a lethal infection of coronaviruses. On Dec. 22, 2020, the company registered a Phase 1 clinical trial of a single dose of the vaccine. DISTRIBUTIONWhile Moderna's clinical trials were still underway in the summer of 2020, the company entered deals with several countries to supply the vaccine pending its approval. On Aug. 11, the United States government awarded the company $1.5 billion in exchange for 100 million doses if the vaccine proves safe and effective. Additional negotiations have increased the agreement to 500 million doses.

Moderna has made similar deals with other countries including Canada, Japan, Qatar and South Korea. The company has also pledged 500 million doses to COVAX, a global vaccine initiative, to supply vaccines to low-income countries. On April 29, Moderna announced they would produce 800 million to 1 billion doses in 2021, and planned to manufacture 3 billion doses in 2022. Phase 2 clinical trials are conducted with larger and more targeted populations — for instance, people who may be at risk for a specific infection. If the study vaccine is considered safe and the immune system responds as expected, then the study vaccine moves into phase 3.

Florida's coronavirus death toll hit 10,000 on Wednesday as the state continues to struggle to get the ongoing pandemic under control. Almost six months since Florida's first case was identified, the state reported 174 deaths on Wednesday, bringing the total death toll to 10,067. The state reported 584,047 Covid-19 cases on Wednesday, up 0.7% from a day earlier, compared with an average increase of 1% in the previous seven days.

The new daily rate of people testing positive for the first time fell to 7.1% for Tuesday, the lowest since June 14. The state has reported 33,146 new cases in the past seven days, the fewest in a comparable period since late June. Vaccines differed substantially in the amount of vaccine per dose in clinical trials — and consequently in the amount of vaccine given to patients. For instance, Moderna vaccines were tested with 100 micrograms of mRNA per dose, while Pfizer-BioNTech was tested with 30 micrograms per dose.

How To Find Online Jobs For Students

Often, work at home opportunities are ones we turn to when looking for part-time work or just a side hustle that will help pay the bills and provide a bit of extra money. Whether you're looking for remote jobs or virtual assistant roles at top companies, or plan on creating your own business, there are thousands of jobs where you can work from home. Pangian is on a mission to unite all five continents by connecting remote-minded companies with remote employees. Their virtual job board provides a robust list of open, remote positions including web development, UX design, content creation, and digital marketing. Whether you're looking for part-time, full-time, or just occasional flex jobs, finding opportunities that allow you to start work immediately is vital for those making ends meet.

There are hundreds of startups looking to put you to work today as a delivery driver, secret shopper, grocery buyer, e-scooter charger, and more. Finding job listings where you can be home-based and start immediately is a bit harder to find. Call center, customer support jobs, search engine marketing, and social media manager roles often require extensive training and/or previous experience. At a minimum, many work at home jobs will need an internet connection. There are many home jobs on the internet for students in which freelancing is the most credited one.

You can do freelancing full-time and part-time depending on the time you can dedicate to it. The best thing about freelancing is that you can earn money in dollars if you succeed to impress your client. If you don't want to try professional freelancing sites such as Fiverr, Upwork, and People per hour, you can start with Facebook groups and even from your Linkedin connections. You might struggle in the start to find the potential customer but be patient and keep trying. For freelancing sites, you'll need to make a strong Gig to let the client think about hiring you.

Your freelancing work can include content writing, graphic designing, CV making, Urdu typewriting and more depending upon your expertise. This job may differ in the amount of pay and its hours of work. The task is to help your clients with staff support, data entry, social media management, website maintenance, research and customer service. With more and more companies in need of virtual assistants, these positions are increasingly in demand. The Internet provides an opportunity for every college student to earn some extra pocket money to manage their expenses. Spend time to learn various part-time opportunities and start earning money by doing online jobs.

If you're a beginner, we would recommend you to start making money with data entry jobs part-time then move to content writing and other skills you're interested in. During the process, keep your LinkedIn profile active so you can increase your professional connections who can later help you to grow. An active social media presence is important for an online expert. Plus, you should keep learning to improve for a better future in your career. As a search engine evaluator you'll rate social media ads and search engines results for relevancy.

You work completely on your own schedule with a maximum of 20 hours per week and that's why this is one of the best online jobs for college students. Flexjobs is a job board for flexible jobs, be they internet work, freelance gigs, alternative employment, or flexible working arrangements. With over 50 categories of flexible work and virtual jobs, it's one of the best one-stop-shops for online jobs for college students, stay-at-home dads and moms, and backpackers. They offer lots of flexible, short-term or long-term online jobs that require little to no experience.

Appen is looking for social media evaluators, data entry clerks, transcriptionists, and more. Flexjobs and Remote.co are job boards that cater specifically to online and remote careers. Make sure you keep your profile public and submit resumes at the beginning of your job search to let recruiters know that you're looking.

Set up job alerts so that you'll never miss a new job opportunity. You can also earn money by selling your photos on websites like Shutterstock.com. Another one is Pakstockphoto.com where you can upload photos to sell it and earn money. This is one of the best online jobs for intermediate students in Pakistan for which you don't need anything instead of your smartphone.

Plus, you can also make an Instagram account to upload your pictures and increase your followers. You never know one day you might become the most followed photographer of Pakistan, keep trying. There are a number of educational platforms that have shifted to online learning. They have a bunch of tutors who are experts in their subjects and teach online to the students in Pakistan.

But you can start small with websites that are reachable according to your subject expertise. You don't need to pay them anything, drop your CV with a letter to join their platform and wait for them to contact you. Search their hiring process before you apply and tailor your CV according to their requirements. It's a better job than data entry if you have the teaching skills and a strong grasp of your subject. You can earn hourly payments or a fixed salary according to the process.

Students can take a look over the social media influencer marketing jobs that are taking the front seat in the social media industry. Being a social media influencer may come with working for one company or more. Promoting and managing the company's online presence via social media handles is the main task. Reviewing, analyzing and contributing to activities on websites like Facebook, Twitter, YouTube, Pinterest and Instagram is a daily task for the social media manager.

Such jobs are available at GigIndia where students have good chance to become social media influencer and work for top brands. Surveys aren't always the most fun gig, but they are one of the easiest online jobs for college students. Survey sites collect consumer data that companies use to improve their products. That's why they're so eager to pay regular people for their opinions. The freelance and remote work economy have opened up a whole new world of online jobs for college students looking to earn money. Gone are the days of competing for the few food service, babysitting, or retail jobs in a small college town.

With a simple, straightforward layout, this virtual job board is a catch-all of remote, work from home jobs from customer service, to web design, to programming. Another option to start working from home immediately is to get into freelance writing or become a blogger who gets into affiliate marketing. If you enjoy research assignments and writing essays, become a professional essay writer with EssayPro. Build your portfolio and client base to get more contracts.

Earn even more by becoming a freelance writer and syndicating your blog content on other websites, where you will get paid from $150 to $750 for every article they accept. Why spend all of your time on Facebook, Twitter and Instagram when you could also be paid for it? If you're studying marketing or communication science this might be a great job experience for your future career. You need fluent language skills and must be able to design and create appealing social media posts. Furthermore, you will also need to be flexible, confident and organised. A social media manager is the face and voice of a business on a number of social media platforms.

Freelancer job opportunities exist on e-commerce service sites like Fiverr, UpWork, Freelancer.com, Surplus Hands, and Toptal. It's a great place to find new clients to run and grow your own freelance business. You have the freedom to choose from inbound projects that interest you and get paid at the rate that you'd want to make. Many of the job postings require previous experience, but with more work samples and good reviews, you'll be able to earn more for every assignment.

With freelancing in the digital era, you have the flexibility to control when, where, and how you work. One of the easiest online jobs is launching an Esty printables business. To learn how to launch a printable business, check out this course, which outlines step by step how you can start an easy online job. Data entry jobs are most widely searched online part time jobs from home for students. They are in great demand these days and you can find these openings from freelancing data entry websites. Here, you will have to enter certain details after searching them over the internet.

You don't have to be an art major to make money online as a graphic designer. Small businesses need appealing graphics for everything including business cards, logos, social media images, and more. Taking online surveys is a quick and easy way to earn money. Survey companies will ask for your opinions on a number of topics and you don't require any special skills or knowledge to answer them.

Usually, the only requirement is that you are 18 years or older. Beware of scam sites that don't pay out or don't offer quality surveys. Stacy offers editing and post-production services to help organizations find their voice in today's saturated media landscape. She edits podcasts to create engaging and immersive results. At a rate of $50 per hour, you can see how this can be one of the best online jobs for college students with the appropriate skills.

This is one of the easiest and most affordable ways to start making money online and work on your own schedule. I hope this list has given you some insight on how to make money online as most of these are online jobs for college students with no experience. You already take tests all the time, why not get paid for some?

This is a great online job for students because companies need feedback on the user experience of their websites and they'll pay you to get it. This is one of the easiest ways and quickest to make money online. Freelancing is one of the best jobs for students because you choose what service you want to provide, which clients you want to work with and you make your own schedule. Here is a list of freelance jobs for college students that you can start today. For people like I who want to work, you've hit a gold mine, because I'm going to show you the best part-time online jobs for college students to earn money. Jobspresso features a wide range of curated jobs in tech, marketing, customer support, and more.

You can search their virtual job board for openings and post your resume to be searched and seen by potential employers. Wolf Careers is a free online job posting board exclusively for Front Range Students. Here students can see postings from employers who open positions for our students. Full-time, part-time, internship and volunteer positions can be found. If you receive an error message please contact Include your first name, last name, student email and S#.

If you want to find full-time or part-time jobs for college students off campus, Career Services at any of the FRCC campuses can help. Additionally, you can use Wolf Careers, FRCC's online job board with exclusive part-time jobs, full-time internships and volunteer positions. JobLink is Student and Community Engagement's online job board, powered by College Central Network for Sinclair. Each year we post over 2600 jobs, including full and part-time, seasonal or temporary positions, internships, apprenticeships, and student employment/work study jobs . There are well over 2500 employers in the system, posting job opportunities and looking for qualified candidates.

Similar to Appen, Lionbridge is among the leading global companies offering online jobs. They offer online gigs for internet raters, online map quality analysts, social media internet assessors, as well as other pay per task opportunities. If data entry sounds appealing, why not consider taking online paid surveys instead of hunting for an Amazon job?

What's more, legit paid survey sites pay significantly better than menial data entry roles, so you'll be more rewarded for your time with this route. Data entry is a low-skill job for which you don't need any degree or expertise to start. You can find various online data entry jobs in Pakistan such as writing the text from the images, converting handwritten data into excel sheets, PDF to word, and many more that.

Small to big organizations look for data entry operators to digitize their manual data. But you must know that it's mundane work and will make you earn in peanuts. We will recommend this if you're a beginner and don't have any skills other than reading and typing. Becoming a virtual assistant tops our list as best online job. Learn about this and other totally legit online jobs that you can start right away.

So, the internet has opened up a wide range of income-generating opportunities for people these days. If you are motivated to work online, then you can choose an online job from the list of 50 online jobs from home and start it as soon as possible. Online data entry jobs require you to input alphabetic, numeric, or symbolic data into a system. It might not sound like tons of fun, but it's an online job that can pay well!

To excel in the role, consider bolstering your skills in computer programs like Microsoft Excel and Microsoft Word. Virtual assistants are hired by businesses that prefer to outsource tasks that don't need to be done in-house. This can include bookkeeping, data entry, or customer services. The amount you can charge as a virtual assistant depends on your skillset and experience.

And if you have specialized skills like managing Facebook ads or email marketing, you can charge a premium rate. While I'd say that the best long-term job for a college student is to become a blogger, if you're looking to earn cash more quickly the best option is to become a virtual assistant. There are so many people looking to hire for this role and there are over 275 different services you can offer so it fits many skill levels. As a result of the COVID-19 outbreak, companies have moved their daily work to online. However, there are still many businesses that have closed and thousands of workers that have lost their jobs.

However, if you have a computer and an internet connection, there are endless new opportunities that you may not even know about! Countless online jobs are hiring individuals who have taken to the online world in search of their next career. With a gorgeous user interface and extensive information about all the companies and jobs they feature, The Muse makes remote job searching feel easy.

Just click the "wireless logo" the site uses for its jobs search and then filter by remote jobs. This is a beautifully designed and easy to use virtual job board, reflective of its focus on providing job opportunities for web designers and web developers. If you use the resources Skip the Drive provides, you can truly swap your ugly morning gridlock for a leisurely telecommute. Virtual Vocations' jobs board features telecommuting positions in job fields like technical writing and paralegal. The site was started by a stay-at-home mom who was frustrated with a lack of legitimate remote job listings online, and today the company is run by an entirely remote team.